Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

VEGFR3/Flt-4 Antibody (AFL4), Biotin, Novus Biologicals™
SDP

Catalog No. NBP14350201 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP14350201 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP14350201 Supplier Novus Biologicals Supplier No. NBP1435020.1MG

Rat Monoclonal Antibody

VEGFR3/Flt-4 Monoclonal specifically detects VEGFR3/Flt-4 in Mouse samples. It is validated for Flow Cytometry.

Specifications

Antigen VEGF R3/Flt-4
Applications Flow Cytometry
Classification Monoclonal
Clone AFL4
Conjugate Biotin
Dilution Flow Cytometry 1:10-1:1000
Formulation Aqueous buffer, may contain carrier protein/stabilizer (proprietary) with 0.09% Sodium Azide
Gene Alias EC 2.7.10, EC 2.7.10.1, FLT-4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
Gene Symbols FLT4
Host Species Rat
Immunogen The immunogen for this antibody was VEGFR3.
Purification Method Affinity Purified
Quantity 0.1 mg
Regulatory Status RUO
Research Discipline Angiogenesis, Cancer, Hypoxia, Protein Kinase
Primary or Secondary Primary
Gene ID (Entrez) 2324
Target Species Mouse
Content And Storage Store at 4C. Do not freeze.
Isotype IgG2a κ
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.